Cargando…
Testing considerations for phosphatidylinositol‐3‐kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer
Breast cancer is the most common cancer in women, and approximately 71% of carcinomas are hormone receptor‐positive (HR+) and human epidermal growth factor receptor 2‐not‐amplified (HER2‐negative). Pathogenesis of breast cancer is associated with dysregulation of several signaling pathways, includin...
Autores principales: | Toppmeyer, Deborah L., Press, Michael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520347/ https://www.ncbi.nlm.nih.gov/pubmed/32697890 http://dx.doi.org/10.1002/cam4.3278 |
Ejemplares similares
-
The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer
por: Chu, Chien-An, et al.
Publicado: (2021) -
Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours
por: CAPODANNO, ALESSANDRA, et al.
Publicado: (2012) -
The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma
por: Pridham, Kevin J., et al.
Publicado: (2017) -
Knockdown of AMP-activated protein kinase alpha 1 and alpha 2 catalytic subunits
por: Tangeman, Larissa, et al.
Publicado: (2012) -
Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway
por: Zhang, Haijun, et al.
Publicado: (2021)